Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

European regulators have for the fourth time issued a negative opinion on PTC's Translarna. Elsewhere, Amylyx read out data ...

CHENGDU, China I October16, 2024 I Chengdu Baiyu Pharmaceutical Co., Ltd. ("Baiyu") today announced that it has entered into an exclusive license ...

Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma ...

Novartis is paying Chengdu Baiyu Pharmaceutical $70 million to add to its crop of cancer candidates. | Novartis is paying ...

Novartis is spending $70 million upfront on a small molecule antitumor drug from the Chinese biotech Chengdu Baiyu. The Swiss ...

U.S. stocks were higher after the close on Friday, as gains in the Financials, Industrials and Consumer Services sectors led ...

BAIYU Holdings shares touched a 52-week low as the stock returned to Nasdaq, over a month after the Securities and Exchange Commission temporarily suspended trading. However, shares could possibly ...

SHENZHEN, China - BAIYU Holdings, Inc. (NASDAQ: BYU), a prominent B2B e-commerce and supply chain service provider, has filed an appeal against the Nasdaq's decision to delist the company's securities ...

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market ® (Nasdaq: NDAQ) announced that trading will resume in BAIYU Holdings, Inc. (Nasdaq: BYU) at 9:00 a.m. Eastern Time on October 9, ...